| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Sep 20, 2023 | Gosebruch Henry O Pres CEO | Buy | Neumora Therapeutics, Inc. | NMRA | $12.62 | $189,371 | +2.78% |
| May 09, 2023 | May 12, 2023 | Gosebruch Henry O Dir | Buy | Acelyrin, Inc. | SLRN | $18 | $900,000 | +50.00% |
| May 16, 2022 | May 20, 2022 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $155 | $13M | -45.95% |
| Mar 01, 2022 | May 20, 2022 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $147.29 | $4M | -20.23% |
| May 16, 2022 | May 18, 2022 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $155 | $13M | -46.00% |
| Mar 01, 2022 | Mar 02, 2022 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $147.29 | $4M | -20.23% |
| Mar 01, 2022 | Mar 01, 2022 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $148.26 | $2M | -10.82% |
| Nov 20, 2020 | Nov 24, 2020 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $99.38 | $4M | -24.32% |
| Jan 10, 2020 | Jan 14, 2020 | Gosebruch Henry O Dir | Buy | Aptinyx Inc. | APTX | $3 | $75,000 | +16.67% |
| Jul 29, 2019 | Jul 31, 2019 | Gosebruch Henry O EVP Chief Strategy Officer | Buy | Abbvie Inc. | ABBV | $67.28 | $2M | +27.77% |
| May 07, 2019 | May 09, 2019 | Gosebruch Henry O Dir | Buy | Aptinyx Inc. | APTX | $3.86 | $385,624 | +50.00% |
| Nov 29, 2018 | Nov 30, 2018 | Gosebruch Henry O EVP Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $90.1 | $4M | -56.90% |
| Oct 30, 2017 | Oct 31, 2017 | Gosebruch Henry O Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $90.55 | $2M | -21.56% |
| Jul 31, 2017 | Aug 02, 2017 | Gosebruch Henry O Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $70.42 | $21,127 | -0.18% |
| Jul 31, 2017 | Aug 02, 2017 | Gosebruch Henry O Chief Strategy Officer | Sell | Abbvie Inc. | ABBV | $70.09 | $1M | -17.46% |